Preparation and biological evaluation of Re-ethylenediamine-N, N, N′, N′-tetrakis(methylene phosphonic acid) as a potential agent for bone pain palliation

Nuclear Medicine Communications

Volumn 23, Issue 1, 2002, Pages 75-81

  Oh, S J ^a   Won, K S ^a   Moon, D H ^a   Cheon, J H ^a   Ha, H J ^a   Jeong, J M ^a   Lee, H K ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

Bone; Diphosphonate; EDTMP; Microwave; Re

Indexed keywords

AMMONIUM PERRHENATE; DRUG CARRIER; ETHYLENEDIAMINE TETRAKIS(METHYLENEPHOSPHONIC ACID); ETHYLENEDIAMINE TETRAKIS(METHYLENEPHOSPHONIC ACID) RHENIUM RE 188; ETIDRONIC ACID RE 186; RADIOPHARMACEUTICAL AGENT; RHENIUM 188; RHENIUM COMPLEX; STANNOUS CHLORIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE METASTASIS; BONE PAIN; CANCER PAIN; CONTROLLED STUDY; DRUG DISTRIBUTION; DRUG STABILITY; DRUG SYNTHESIS; DRUG UPTAKE; MALE; MICROWAVE RADIATION; NONHUMAN; PALLIATIVE THERAPY; PH; RADIOCHEMISTRY; RAT;

ANIMALS; BONE NEOPLASMS; HYDROGEN-ION CONCENTRATION; INDICATORS AND REAGENTS; ISOTOPE LABELING; LIGANDS; MALE; ORGANOMETALLIC COMPOUNDS; PAIN, INTRACTABLE; RADIOISOTOPES; RADIOPHARMACEUTICALS; RATS; RATS, WISTAR; REDUCING AGENTS; TISSUE DISTRIBUTION;

EID: 0036191337     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/00006231-200201000-00012     Document Type: Article

References (22)

1. Eary JF, Collins C, Stabin M, et al. Samarium-153-EDTMP biodistribution and dosimetry estimation. J Nucl Med 1993; 34: 1031-1036.
2. Farhanghi M, Holmes RA, Volkert WA, Logan W, Singh A. Samarium-153-EDTMP: pharmacokinetic, toxicity and pain response using an escalating dose schedule in treatment of metastatic bone cancer. J Nucl Med 1992; 33: 1451-1458.
3. Collins C, Eary JF, Donaldson G, et al. Samarium-153-EDTMP in bone metastases of hormone refractory prostate carcinoma: a phase I/II trial. J Nucl Med 1993; 34: 1839-1844.
4. 153Sm in rats. Appl Radiat Isot 1994; 45: 949-953.
5. Louw WK, Dormehl IC, van Rensburg AJ, et al. Evaluation of samarium-153 and holmium-166-EDTMP in the normal baboon model. Nucl Med Biol 1996; 23: 935-940.
6. 225Ac in tumor-bearing mice. Nucl Med Biol 1997; 24: 367-372.
7. 177Lu-EDTMP: a potential therapeutic bone agent. Nucl Med Commun 1998; 19: 587-591.
8. 186Re complex of 3-amino-1-hydroxypropylidene-1, 1-bisphosphonic acid in mice. Nucl Med Commun 1999; 20: 551-557.
9. 188Re) Re-AEDP and its biodistribution studies. Appl Radiat Isot 2000; 53: 993-997.
10. Knapp FF, Jr. Rhenium-188-a generator derived radioisotope for cancer therapy. Cancer Biother Radiopharm 1998; 13: 337-349.
11. Blower PJ, Lam ASK, O'Doherthy MJ, Kettle AG, Coakley AJ, Knapp Jr FF. Pentavalent Re-188 dimercaptosuccinic acid for targeted radiotherapy: synthesis and preliminary animal and human studies. Eur J Nucl Med 1998; 25: 613-621.
12. 188Re and a study of its stability. Appl Radiat Isot 1998; 49: 351-356.
13. Lin WY, Lin CP, Yeh SJ, et al. Rhenium-188 hydroxyethylidene diphosphonate: a new generator-produced radiotherapeutic drug of potential value for the treatment of bone metastases. Eur J Nucl Med 1997; 24: 590-595.
14. Lin WY, Heish JF, Lin CP, et al. Effect of reaction conditions on preparation of rhenium-188 hydroxyethylidene diphosphonate complexes. Nucl Med Biol 1999; 26: 455-459.
15. Hsieh BT, Hsieh JF, Tsai SC, Lin WY, Wang SJ, Ting G. Comparison of various rhenium-188-labeled diphosphonates for the treatment of bone metastases. Nucl Med Biol 1999; 26: 973-976.
16. Maxon 3rd HR, Schroder LE, Washburn LC, et al. Rhenium-188(Sn)HEDP for treatment of osseous metastases. J Nucl Med 1998; 39: 659-663.
17. Palmedo H, Guhlke S, Bender H, et al. Dose escalation study with rhenium-188 hydroxyethylidene diphosphonate in prostate cancer patients with osseous metastases. Eur J Nucl Med 2000; 27: 123-130.
18. Goeckeler WF, Edwards B, Volkert RA, Holmes RA, Simon J, Wilson D. Skeletal localization of samarium-153 chelates: potential therapeutic bone agents. J Nucl Med 1987; 28: 495-504.
19. Deutsch E, Libson K, Vanderheyden JL, Ketring AR, Maxon HR. The chemistry of rhenium and technetium as related to the use of isotopes of these elements in therapeutic and diagnostic nuclear medicine. Nucl Med Biol 1986; 13: 465-477.
20. McLean JR, Blakey DH, Douglas GR, Kaplan JG. The effect of stannous and stannic (tin) chloride on DNA in Chinese hamster ovary cells. Mut Res 1983; 119: 195-201.
21. 186Re-HEDP. Inorg Chem 1997; 36: 3055-3063.
22. 99mTc-HEDP complexes. Appl Radiat Isot 1987; 38: 611-614.